A distinct sub-group of B-cell precursor acute lymphoblastic leukemia, defined by intrachromosomal amplification of chromosome 21 (iAMP21), is restricted to older children and has been associated with a poor outcome. Accurate diagnosis is important for appropriate risk stratification for treatment. It could be improved by understanding the initiating mechanism. iAMP21 is characterized by amplification of a 5.1 -24 Mb region of chromosome 21, which includes the RUNX1 gene. It is thought to arise through a breakage -fusion -bridge (BFB) mechanism. Breakpoints initiating BFB cycles were determined from recent array data from 18 patients. Three occurred within the PDE9A gene. Other patients with breakpoints in PDE9A were identified by fluorescence in situ hybridization and molecular copy number counting. Sequencing defined a 1.7 Kb breakpoint cluster region, positioned 400 bp distal to an extensive region enriched for CA repeats with the potential to form Z-DNA. None of the rearranged sequences showed the inverted repeat structure characteristic of BFB; instead PDE9A was fused to intergenic regions of chromosome 21 or to genes on other chromosomes. These observations indicated that previously unrecognized complex events, involving microhomologymediated end joining, preceded or accompanied initiation of the BFB cycle. A chi-like heptomer, CCTCAGC, contained four of the breakpoints, two within PDE9A and two within partner Alu-repeat sequences. This heptomer was closely homologous to a breakpoint hotspot within the TCF3 gene, suggesting involvement of a common novel recombinogenic mechanism that might also contribute to the recombinogenic potential of Alu repeats. These findings provide insight into potential mechanisms involved in the formation of iAMP21.
INTRODUCTION
Detailed investigation of constitutional or somatic reciprocal translocation breakpoints has revealed clues about the mechanisms by which they arise. For example, heptomer/nonomer recombination signal sequences (RSS), specific for the V(D)J-activating RAG1 and RAG2 proteins, are consistently found on one side or straddling breakpoints of immunoglobulin (IG) or T cell receptor (TCR) gene rearrangements, which activate oncogenes in lymphoid malignancy (1, 2) . As RAG1 and RAG2 facilitate normal IG and TCR rearrangements, this could be predicted. More surprising was the discovery that heptamer/nonomer-like sequences were found at the breakpoints of their partner genes and at breakpoints of non-IG/TCR rearrangements (3) . Furthermore, RAG1 is capable of creating double-strand breaks at single base pair mismatches, such as those arising as a result of AID-mediated deamination of methyl CpG (4) .
Within limits imposed by the requirement to juxtapose specific exons or regulatory sequences, fusion-oncogene translocation breakpoints are not always randomly distributed, but often concentrate in regions of less than one to a few Kb. It has † The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. * To whom correspondence should be addressed. Tel: +44 1912821320; Fax: +44 1912821326; Email: christine.harrison@newcastle.ac.uk ‡ The authors wish it to be known that, in their opinion, the last two authors should be regarded as joint Last Authors.
been widely postulated that these breakpoint cluster regions (BCRs) are stretches of chromatin able to adopt unusually open conformations, with increased accessibility to sequencespecific recombinogenic proteins or other DNA-breaking agents. The positions of several experimentally defined chromatin structural elements-in vivo topoisomerase II cleavage sites, DNase 1 hypersensitive sites and matrix/scaffold attachment regions-have been correlated with BCRs in myeloid leukemias (reviewed in 5). In pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) BCRs have been identified within the TCF3 (E2A) and PBX1 genes, that become fused as a result of the translocation, t(1;19)(q23;p13), and in ETV6 (TEL) and RUNX1 (AML1), disrupted by the translocation, t(12;21)(p13;q22). In the TCF3 gene, 16 of 24 breakpoints occurred within 5 bp of each other (6) . The BCRs in PBX1 and RUNX1 have not yet been elucidated, but in ETV6 a cluster of breakpoints spanned a polymorphic 206 -233 bp purine/pyrimidine tract, that formed paranemic structures in vitro (7, 8) . Interestingly, breakpoints in T-ALL, T-and B-cell lymphoma have been positioned to within, or near, similar purine/pyrimidine or oligopurine/oligopyrimidine repeats (9 -11) .
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a subgroup of pediatric BCP-ALL with a poor prognosis on standard therapy (12) , for which appropriate risk stratification for treatment requires accurate detection. iAMP21 is characterized by gross abnormalities of chromosome 21 visible at the cytogenetic level, within which a common region of amplification always includes a minimum of three additional copies of the RUNX1 gene. Although there is no evidence that RUNX1 is the target of iAMP21 amplification, fluorescence in situ hybridization (FISH) with probes to this gene remains the most reliable detection method. Using a combined genomic approach, we showed that the amplified regions of chromosome 21 were highly variable in size between patients. Both FISH and chromosome 21 array profiles indicated a series of complex inversion/duplication events, consistent with a breakage -fusion -bridge (BFB) mechanism of intrachromosomal amplification (13, 14) . Furthermore, anaphase bridges involving chromosome 21 were observed in some iAMP21 patients, consistent with on-going BFB cycles (15) . In the present cohort of patients, data from a higher resolution array set have been used to define the position of the breakpoints initiating the BFB cycles leading to iAMP21. Several of these breakpoints were clearly non-random, providing the opportunity to investigate, for the first time, a BCR associated with amplification in a hematological malignancy.
RESULTS
Evidence from array-based comparative genomic hybridization that iAMP21 abnormalities originate from BFB cycles and are initiated from recurrent breakpoints Array-based comparative genomic hybridization (aCGH) was carried out on samples from 18 patients with iAMP21. Their corresponding demographic and cytogenetic data are provided in Supplementary Material, Table S1 . A step-wise rise in copy number in a centromeric to telomeric direction, followed by a sharp drop off to deletion or normal diploid levels, was observed in 13 of the genomic profiles. These patterns were consistent with the classical BFB cycle of oncogene amplification (16) . Similar increases in copy number, punctuated by regions of deletion, were seen in patients 8983 and 7619, while patients 7255, 9028 and 7828 had more complex profiles. Examples of the various profiles are shown in Figure 1 .
According to theoretical models, the BFB cycle is initiated through the loss of a telomere or through one double-strand DNA break, positioned telomeric to the target oncogenic region. The initiating breakpoint in iAMP21 can therefore be located from array data, to the point where the most telomeric amplified probes give way to probes that are deleted or of normal copy number. In this study, amplification was initiated from the telomere in two patients (6783, 9864). For remaining patients, initiating breakpoint regions were positioned between nucleotides 39,019,555 and 47,822,296 of chromosome 21, as indicated in Table 1 . Breakpoint regions fell within known coding genes in 11 patients, while all others either contained or overlapped with a known gene. G/C content of breakpoint regions was unexceptional, ranging from 40.47 to 62.45, and repeat content was highly variable, between 1.5 and 69% (Table 1) . Notably, recurrent breakpoint regions were defined within PDE9A by patients 4279 and 6111 and within COL6A by patients 7583 and 9028. 
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FISH and molecular copy number counting confirm amplification/deletion junctions are recurrent within PDE9A
To investigate further the apparent clustering of breakpoints, we performed FISH and molecular analysis of the recurrent breakpoint region, which fell within the PDE9A gene, between genomic positions 21:44081762 and 21:44094899.
A two-color break-apart FISH probe targeting the PDE9A gene was designed ( Fig. 2A) and FISH was performed on 13 of the patients analyzed by aCGH, for which fixed cells were available (as indicated in Table 1 ). An initiating breakpoint within PDE9A, defined by amplification of the red (centromeric) part of the probe accompanied by loss or diminution of the green (telomeric) probe, was observed in three patients In the aCGH profiles, a fluorescence intensity ratio corresponding to normal copy number is marked by the yellow bars; the position of the initiating breakpoint, within the red box, is most easily appreciated from the whole chromosome 21 profile (upper panel). A detailed view of the initiating breakpoint region (lower panel) clearly demonstrates transition from amplified to deleted probes occurring within the PDE9A gene (position marked by red band). FISH produced a single fusion signal, corresponding to the normal chromosome 21, and a cluster of red signals indicating amplification of the centromeric and deletion of the telomeric probes respectively. MCC data also indicate a change in copy number within PDE9A and refine the breakpoint to between markers M2 and M7 within intron 1.
(as indicated in Table 2 and illustrated for patient 4279 in Fig. 2B ). In all other samples, FISH showed either loss or amplification of the entire probe in agreement with the aCGH profiles. A further 54 iAMP21 patients, not analyzed by aCGH, were tested with the same PDE9A probe. Three patients showed a breakpoint within PDE9A as above. The remaining cases had two normal copies of the gene (n ¼ 11), a single copy, indicating deletion of the entire gene (n ¼ 16), and multiple fusion signals, indicating amplification of the entire PDE9A gene (n ¼ 24). In total, initiating breakpoints were shown to occur within PDE9A by aCGH and/or FISH in 6 of the 71 patients analyzed (Table 2) .
To more accurately map the position of breakpoints within PDE9A, we used molecular copy number counting (MCC). Two patients, 4279 and 6111 with breakpoints defined to within a 13 Kb region of intron 1 by aCGH, were initially analyzed using six markers (M1 -6) at 2 Kb intervals (Supplementary Material, Table S2 ). A reduction in copy number, indicating the position of a breakpoint, occurred between markers M2 and M3 in both patients. Breakpoint positions within this region were further refined using three more closely associated markers (M7 -9) at 300 bp intervals within this region (Supplementary Material, Table S2 and Fig. S2B ). In addition, cryptic rearrangements within PDE9A were identified in three patients, who-by aCGH and FISH-were deleted for the entire gene. In patients 7619 and 6996, all markers telomeric to M2 were deleted, while in 8983 a small interstitial deletion involving markers M7 -9 occurred. Of the four patients with breakpoints defined within PDE9A by FISH alone, 7024 and 7828 had diminished green signals co-localizing with the amplified red signals, indicating that the breakpoints fell distal to exon 3, within the region covered by the green FISH probes. In the remaining two patients, 2647 and 3745, the pattern of signals was consistent with a breakpoint occurring centromeric to the green probes (within the proximal 30-40 Kb of PDE9A). These latter two patients were not tested by MCC, although they had breakpoints identified by long-distance inverse PCR (LDI-PCR), described below, using primers covering the intron 1 BCR defined in patients 4279, 6111, 6996, 7619 and 8983. Therefore, among nine patients with breakpoints within PDE9A, seven clustered within intron 1, while two were more distally positioned (Table 2 ).
Sequence analysis demonstrates that rearrangements of PDE9A are tightly clustered and unexpectedly complex Based on the above data, LDI-PCR primers were designed to amplify the clustered PDE9A intron 1 breakpoints (Supplementary Material, Table S3 ). Fusion sequences were obtained for five patients with DNA of sufficient quality (2647, 3745, 4279, 6996, 8983). Theoretical models of the BFB cycle predict an inverted repeat structure at initiating breakpoints. However, despite strong evidence that iAMP21 abnormalities arise through BFB cycles, inverted repeats were not seen in any of these cases. Where rearrangements involved chromosome 21 only, sequences flanking the breakpoint were in the same centromeric to telomeric orientation. Even more surprisingly, in patients 4279, 6996 and 8983, PDE9A intron 1 was fused, respectively, to intron 12 of the MUS81 gene at chromosome band 11q13, intron 3 of the VWF gene at 12p13.3 and to the 3 ′ untranslated region of the REXO1L1 gene at 8q21.2. The PDE9A -MUS81 and PDE9A -VWF translocations therefore potentially resulted in the production of in-frame fusion genes, but the translocation to REXO1L1 would have produced a truncated PDE9A protein and full-length REXO1L1 protein, which may have been produced at abnormal levels, since the loss of the wildtype 3 ′ UTR would very likely have influenced mRNA stability. In patients 2647 and 3745, deletion of intron 1 was accompanied by insertion of sequences 5 ′ and 3 ′ to PDE9A, respectively. The cluster of breakpoints within PDE9A intron 1 spanned 1.7 kb between 21:44083850 and 21:44085593. The structure of wild-type genes, rearranged fusion sequences and position of breakpoints are illustrated in Figure 3 . Where possible, fusion sequences were verified by complementary techniques. The PDE9A -MUS81 fusion in patient 4279 was confirmed by genomic PCR with novel primers and was shown to be transcribed and spliced by reverse transcription PCR (RT -PCR). Genomic PCR was used to confirm the PDE9A -VWF fusion sequences in patient 6996. Changes in copy number within MUS81 and VWF were also detected by MCC using additional markers flanking the breakpoints. The sequences translocated to chromosome 21 were amplified in both cases. However, amplification of these genomic regions was not detected by aCGH or FISH, using an 200 Kb, two-color break-apart probe that spanned the breakpoint in MUS81. These results suggested that relatively small segments of non-chromosome 21 sequence were fused to PDE9A.
Sequences at breakpoint junctions are consistent with the involvement of a non-homologous end-joining repair pathway and show evidence for RAG1 activity Alignment of wild-type sequences flanking breakpoints, with the fusion sequences, revealed regions of micro-homology from 1 to 7 nucleotides in length in all patients except 4279 ( Fig. 4A and Supplementary Material, Fig. S1 ), suggesting that breaks were resolved through a non-homologous endjoining repair pathway (17) . Extended regions of homology, associated with homologous recombination repair, were not seen. Examination of the breakpoint regions revealed V(D)J heptamer-nonamer RSS-like sequences and CpG dinucleotides in close proximity to at least one breakpoint in all patients (Supplementary Material, Fig. S1 ). On the '-' strand, breakpoints within PDE9A had a median distance from CG of 1.5 bp. However, the PDE9A BCR was extremely 
CG rich, with randomly derived breakpoints across the 1.7 Kb region having a median distance of 3 bp from a CG dinucleotide on the ' -' strand. On the '+' strand median observed and random breakpoints were, respectively, 8 and 19 bp from a CG sequence. On the partner sequences, CG dinucleotides were seen close to five of the seven breakpoints. CAC trinucleotides, considered to be the minimal requirement for V(D)J-type RAG activity (4), showed median distances of 10.5 and 6.5 bp on the '+' and '2' strands, respectively, for observed breakpoints within the PDE9A BCR. This compares with median distances of 17.5 on the '+' and 26 bp on the '2' strands for randomly derived breakpoints. Thus, breakpoint positions were suggestive for both CpG-and V(D)J-type RAG activity, although P-values for the differences between observed and random data sets, which ranged between 0.324 and 0.742, were not significant. 
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Analysis of breakpoint regions implicates involvement of Alu repeats, a Chi-like heptomer and an extensive region enriched for Z-forming DNA
In patients 2647 and 3745, small segments of intergenic chromosome 21 sequence were inserted into sites of deletion in PDE9A. The most centromeric breakpoints within PDE9A were positioned to the same 7 bp region with microhomology to different partner sequences, one 5 ′ and the other 3 ′ , of PDE9A (Fig. 4A) . The partner sequences also showed homology to each other over a more extended region (Fig. 4B) . Alignment of surrounding sequence with a reference collection of known repeats demonstrated that the breakpoints fell within similar, AluSx and AluSx1, repeats. The unusually tight clustering of the two breakpoints in PDE9A is reminiscent of those previously reported within the TCF3 gene that resulted from translocations with PBX1 or HLF in pediatric BCP-ALL (6, 18, 19) . Comparison of the 7 bp region of microhomology, together with flanking PDE9A sequences, with the TCF3 BCR sequence revealed 8 nucleotides, CCTCAGCG, from PDE9A that aligned, with only one mismatch, with part of the TCF3 sequence (Fig. 4C) . Furthermore, the aligned octamers contained the 7 bp region of microhomology and 19 of 20 TCF3-PBX1/TCF3-HLF breakpoints. We also noted that the heptamers were similar to the chi element, CCACCAGC, which mediates RecBCD-dependent recombination in prokaryotes (20) . We then analyzed the repeat content of the PDE9A BCR and 2.5 Kb flanking sequences. This revealed only a single MLT1 repeat that coincided with the telomeric breakpoints in patient 2647. The breakpoints within the MUS81 and REXO1L1 genes fell within similarly repeat-poor regions and in neither case coincided with a repeat. However, the breakpoint within the VWF gene occurred within a MER31 repeat in a region containing several blocks of Alu and non-Alu repeats. This breakpoint was also only 56 bp from an AluSx repeat, bearing close homology to the rearranged Alu sequences in patients 2647 and 3745. Thus, breakpoints analyzed at the sequence level were all from within-coding genes and/or repeat-rich regions, with an apparent tendency to occur within or close to AluSx or AluSx1 sequences (Fig. 4D) . Comparison of median distances between observed and randomly generated breakpoints and AluSx or AluSx1 repeats (Table 3) suggested involvement of Alu sequences in five out of the seven cases.
We then scanned intron 1 of PDE9A for other features that might underlie the clustering of breakpoints. Regions requiring a low free energy level (DG) to unwind double-stranded supercoiled DNA have been correlated with breakpoints in malignancy (5) and a region of low DG was identified 4 Kb distal to the 1.7 Kb breakpoint cluster. Of more likely significance, we noticed an 1 Kb region positioned 400 bp 5 ′ of the cluster that was highly enriched in CA repeats. Using an algorithm designed to identify regions prone to form Z-DNA, approximately half of this sequence was classified as Z-DNA-forming regions (ZDR). Several unclassified CD4+ cell-type-specific regulatory features, consisting of DNase 1 hypersensitive sites and regions enriched for specific histone modifications, are located within PDE9A intron 1. Two of these, ENSR00000185924 and ENSR00000185925, overlapped with the breakpoint cluster and the most 5 ′ region of histone modification coincided with the start of the ZDR-enriched sequence (Fig. 5) . We next interrogated 20 Kb regions containing the sporadic partner breakpoints for ZDR. Short, ,20 bp, Z-forming DNA sequences were identified within 270 bp of four of the seven breakpoints. Comparison with the mean and median distance between breakpoints generated randomly across these regions and ZDR (Table 3 ) suggested more than a chance association between ZDR proximity and some iAMP21-associated breakpoints. In addition to proximity to a ZDR, we noted that the chromatin environment of the breakpoint region in the REXO1L1 gene resembled that of the PDE9A BCR in that it was marked by a DNase 1 hypersensitive site in multiple cell lines, including the hemopoietic line K562. The MUS81 breakpoint was also associated with a ZDR but no other recognized features associated with an openchromatin environment, while the VWF breakpoint region contained no ZDR but was within a site that was DNase 1 hypersensitive and enriched for H3K4me3, as seen in human umbilical vein endothelial cells.
Extensive tracts of Z-DNA-forming sequence, such as that associated with the breakpoint cluster, were not seen in any of the partner regions. Z-forming DNA generally also constituted only a small fraction of sequence in the 12 other initiating breakpoint regions of chromosome 21 (Table 1) and only one, patient 7045, contained a Z-DNA-enriched sub-region similar to that found close to the PDE9A exon 1 BCR.
DISCUSSION
By focusing on a cluster of breakpoints occurring in iAMP21, we have identified several important features relating to individual breakpoints, origin of the BCR and the mechanism of amplification. First, in agreement with the previously published findings (13) (14) (15) , array data implied that the mode of amplification was through BFB cycles, yet none of the sequenced junctions at the initiating breakpoints showed the inverted repeat structure characteristic of this mechanism. Instead complex insertion/deletion events within chromosome 21 and among other chromosomes were observed. In the BFB cycle model, amplification is initiated following a G1 doublestrand break and DNA replication, when the two broken sister chromatids are joined to form a dicentric chromosome (16) . Based on our data, it appears that in iAMP21 patients, double-strand breaks are initially more likely to be resolved by fusion to sequences other than the homologous chromatid, suggesting a cellular environment that is rich in fragmented chromosomes. As far as these rearrangements could be characterized, only relatively small intergenic regions of chromosome 21, or other chromosome sequence, were inserted at the initiating breakpoint sites. Whether or not these small insertions originated from larger chromosomal regions, which subsequently underwent further rearrangement, is unclear. However, BFB cycles must eventually have been established and the rearrangements stabilized through telomere acquisition, without dicentric formation. Paradoxically, while complexity of iAMP21 breakpoint junction sequences is suggestive of an unstable chromosomal environment, karyotypes and global genomic profiles of iAMP21 patients are relatively simple, by comparison with many other cases of ALL (13) . Thus, iAMP21 clones may pass through a temporary phase of genomic instability. Perhaps indicating a common mechanism of underlying instability, solid tumor amplicons sometimes involved inter-as well as intra-chromosomal rearrangements, with the most complex consisting of clusters of tens to hundreds of DNA fragments, from 20 bp to a few Kb in length (21) . Recent evidence demonstrates that in some 2 -3% of cancers overall, similar rearrangements arise as a single catastrophic event that has been termed chromothripsis (22) . Although amplification in iAMP21 must take place over several cell cycles, it seems plausible that the initiating event involves chromothripsis of chromosome 21 since this would explain the unexpected nature of the PDE9A rearrangements, the cytogenetic heterogeneity of iAMP21 marker chromosomes and the complexity of some array profiles. In 9 of the 71 patients analyzed, we observed breakpoints within PDE9A. This gene is a member of the phosphodiesterase family that plays an important role in signal transduction through regulating intracellular concentrations of cyclic nucleotides (23) . It has multiple splice forms and is expressed in all tissues so far examined. However, expression was not detected in several leukemia and lymphoma cell lines, making it a potential candidate tumor suppressor gene (24) . ′ to the cluster, contained within the large box, is highly enriched for CA repeats and sequences predicted to form Z-DNA (marked by grey infill). The small box marks the 5 ′ end of the breakpoint cluster. Lower diagram summarizes the spatial relationship between Z-DNA forming sequence (white), breakpoints (arrows) and CD4+ lineage-specific DNAse 1 hypersensitive sites (black). The positions of CD4+ lineage-specific regions enriched for different histone modifications are also shown (broken lines).
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It, therefore, cannot be excluded that in these patients, as well as in iAMP21 patients deleted for the entire gene, that the loss of PDE9A function contributed to the malignant phenotype. However, deletions of PDE9A were not observed without accompanying amplification of more proximal regions of chromosome 21 and, in the majority of iAMP21 patients, PDE9A was not deleted (13) . It is also possible that disruption or fusion of the non-chromosome 21 genes to PDE9A contributed to leukemia. MUS81 plays an essential role in DNA repair during replication (25) and MUS81+/2 and 2/2 mice spontaneously develop tumors (26) . Therefore, disruption of MUS81, or production of a dominant negative form of the gene, may have contributed to leukemogenesis. The VWF gene is a coagulation factor, under expression of which results in von Willebrand's disease (27) . However, it has not been associated with malignancy. Likewise the RNA exonuclease, REXO1L1, although currently of uncertain function, has no known role in malignant disease. Although we cannot exclude a leukemogenic role for lost or altered PDE9A, MUS81, VWF or REXO1L1 function, the cluster of breakpoints occupied only 1.7 Kb of intron 1, which spans .32 Kb. Therefore, even if truncated or chimeric PDE9A proteins confer some growth advantage, the existence of such a specific BCR within PDE9A is likely to reflect mechanistic rather than pathologic factors. The PDE9A intron 1 BCR and flanking sequences encompass several, probably interrelated, genomic features that might contribute to local instability (Fig. 5) . First, two DNase 1 hypersensitive sites, accompanied by regions of differential histone modification, have been mapped to within and just 3 ′ of the intron 1 BCR. DNase 1 hypersensitive sites have previously been correlated with BCRs in leukemogenic fusion-gene partners including; AFF1, MLLT3, RUNX1, RUNX1T1 and BCR (28 -30). However, similar sites of DNase 1 hypersensitivity and differential histone modification within other regions of PDE9A have not been associated with clustered iAMP21 breakpoints; thus these features alone are unlikely to explain the BCR described here. A more unusual feature, positioned 400 bp proximal to the 5 ′ end of the BCR and coinciding with the proximal regions of histone modification, consisted of an 1 Kb tract highly enriched for purine -pyrimidine repeats. Much of this region was predicted to potentially adopt an open left-handed double-helical structure, known as Z-DNA. The extent to which Z-DNA exists in-vivo is uncertain but it is thought to form transiently during transcription as superhelical DNA is unwound by DNA polymerase II (Pol II). Several proteins have been shown to bind specifically to Z-DNA (31, 32) . They may stabilize the Z conformation in the absence of Pol II activity, making chromatin accessible to DNA-interacting factors. Helical distortion induced by the transition from B to Z-DNA may also make ZDR unusually fragile. Whatever the underlying mechanisms, there is clear evidence for an association between Z-DNA and recombination because reporter plasmids containing ZDRs induce genetic instability both in vitro and in vivo (33, 34) . In addition, leukemia and lymphoma breakpoint positions have been correlated with the presence of sequences with potential to form Z-DNA (7 -10,35,36) . In comparison with these previous reports, the region enriched for CA repeats in PDE9A is larger, with breakpoints covering a somewhat wider area. ZDR occurs in the genome approximately every 3 Kb (37); however, these are typically isolated and ,30 bp in length. Taken together with the positions of breakpoints, DNase 1 hypersensitive sites and differentially modified histones, it is likely that the ZDR cluster in PDE9A functions to initiate or maintain an extensive downstream region of open chromatin that is accessible to recombinases or other factors producing DNA breaks. Short ZDR were found close to four of the sporadic partner breakpoints, further supporting the association between these sequences and genomic instability in ALL.
Examination of the sequences flanking breakpoints revealed potential target sequences of RAG1 recombinase activity at or close to all of the breakpoints within PDE9A and four of the partner sequences. None of the rearrangements within PDE9A resulted in fusion to normal targets for RAG activity; however, a second hallmark of RAG-mediated recombination, microhomology between partner sequences, was also seen in all but one of the rearrangements. Therefore, mistargeted RAG1 activity may have been involved in the PDE9A rearrangements. Both CpG-and V(D)J-type RAG1 target sequences were extremely frequent throughout the PDE9A BCR, and comparison between observed and random data sets was not statistically significant. However, the number of sequenced breakpoints was small, and the median distance between observed breakpoints and these sequences was consistently lower than median distances for random breakpoints in the region. Involvement of RAG1 in the generation of iAMP21 breakpoints would indicate a pre-B rather than lymphoid myeloid hemopoietic stem cell origin for these rearrangements. Among the sequenced PDE9A and partner breakpoints, four were defined within the same 7 bp sequence, CCTCAGC, that aligned with only one mismatch to a sequence containing a cluster of breakpoints in the TCF3 gene (6) . This sequence similarity would also support a pre-B cell origin for the iAMP21 rearrangements as TCF3 translocations are thought to arise at this stage. The heptamers are not only similar to the prokaryotic Chi element but also to a Chi-like conserved human minisatellite, CC[A/T]CC[A/T]GC that has previously been found at oncogenic breakpoints (38) , raising the possibility that a novel sequence-specific recombinase is involved in the production of double-strand breaks leading not only to BCP-ALL but also other malignancies. Alternatively, as has been suggested for TCF3 translocations (4), the heptomer may be the target for CpG-type RAG activity. Why these specific sequences should be more vulnerable to RAG activity than neighboring CpG sites, however, remains unclear.
Two of these sequence-specific breakpoints occurred within Alu repeats which have been implicated in the generation of leukemogenic rearrangements. A 26 bp conserved core region of Alu was reported to be consistently close to, or within recombination sites (39) . The breakpoints in our patients did not coincide with the Alu conserved core, so it is possible that the CCTCAGC motif is a second sequence contributing to the involvement of Alu repeats in recombinogenic events. Since all PDE9A partner breakpoints fell either within a protein coding gene or within or very close to AluSx or AluSx1 repeat, we speculate that these repeats, like active genes, create an open-chromatin environment, which is more prone to the formation of double-strand breaks than surrounding DNA.
The findings described here provide insight into mechanisms underlying the formation of a recurrent amplicon in pediatric BCP-ALL. Future investigations, using advanced sequencing technology, will establish whether the molecular landscape of iAMP21 overall is as complex as suggested by the analysis of rearrangements involving PDE9A. Such studies will also determine the relative importance of specific recombination mechanisms verses random breakage or catastrophic chromothripsistype events.
MATERIALS AND METHODS

Patient samples
DNA extracted from the bone marrow of 18 iAMP21-positive ALL patients was available from local laboratories and the Leukaemia and Lymphoma Research Childhood Leukaemia Cell Bank. The research was approved by the relevant institutional review boards and written informed consent was given by patients, parents or guardians. Fixed cell suspensions from cytogenetic preparations were obtained from 13 of these patients and from a further 54 BCP-ALL patients with iAMP21. Diagnostic cytogenetic and FISH analysis was performed in the UK regional cytogenetic laboratories, and karyotypes, according to the International System for Human Cytogenetic Nomenclature (40) , are described in Supplementary Material, Table S1 .
aCGH and FISH
Processing for aCGH analysis, using the Agilent Human Genome CGH Microarray kit 185K, and interpretation of data were performed as previously described (41, 42) . Additional analysis, visualization and data interpretation were performed using custom software SNPView2 (Ilixa, Nottingham, UK). Regions showing aberrant copy number changes were mapped according to the human reference sequence (hg19). Data are available for download from Gene Expression Omnibus (GSE26192). Five fosmid clones were differentially labeled to construct a FISH probe, designed to detect changes in copy number occurring within the PDE9A gene (Fig. 2) . Names and genomic positions of probes labeled in red were G248P87335G2 (21:43989416 -44025826), G248P8283A3 (21:44019571-44059957) and G248P84236D6 (21:44063799-44106476), and of probes labeled in green were G248P86904G6 (21:44109900 -44153987) and G248P83754D4 (21:44152665 -44196839). A second probe, designed to produce a red-green fusion signal at the PDE9A -MUS81 translocation identified by sequencing in patient 4279, was constructed from the three red-labeled PDE9A probes covering the 5 ′ PDE9A region and two fosmids labeled in green, G248P81985C2 (11:65623920-65662721) and G248P89301D12 (11:65666104 -65707315) from the 3 ′ region of MUS81. Probes were labeled with Spectrum Green or Spectrum Red by nick translation. Hybridization, washes and image capture were performed using standard approaches and 100-200 interphase cells were analyzed. All clones were obtained from the Sanger Centre, Cambridge, UK and genomic locations correspond to release GRCh37 of the human genome project.
Molecular copy number counting (MCC)
MCC was performed, as previously described (41, 43) , by amplifying target genomic markers in samples with subgenome concentrations of DNA [0.03 genomes (0.09 pg DNA)/ml] using three PCR primers, external forward, internal forward and common reverse. In addition to primer sets within PDE9A, markers flanking the breakpoints in MUS81 and VWF were used to confirm that copy number changes occurred within these genes in patients 4279 and 6996. The genomic location of markers and corresponding primer sequences are shown in Supplementary Material, Table S2 . The presence or absence of the PCR product in each well was scored using microplate array diagonal gel electrophoresis (MADGE)-specific gel image analysis software (Phoretix Ltd, Newcastle, UK).
LDI-PCR, RT -PCR and genomic PCR
LDI-PCR was performed as previously described (44) using restriction enzymes, external and internal forward and common reverse primers shown in Supplementary Material, Table S3A . Primers used to confirm fusion genes by genomic PCR are shown in Supplementary Material, Table S3B and to demonstrate expression of the fusion transcript in patient 4279 by RT-PCR in Supplementary Material, Table S3C .
Analysis of breakpoint regions
The position of all breakpoints, genes, repeats and other genomic features correspond to release GRCh37 of the human genome project. Gene and exon-intron boundary positions were as annotated in the Ensembl human genome browser, http://www.ensembl.org/index.html. Z-hunt online software, http://gac-web.cgrb.oregonstate.edu/zDNA/, was used to determine the position of sequences with the potential to form Z-DNA and the % GC content of breakpoint regions. A sequence was considered to be a ZDR if it exceeded a P Z of 700 (45) . Repeat content and the position of Alu sequences were determined using the CENSOR website, http://www. girinst.org/censor/help.html. Random breakpoints were assigned to every 0.5 Kb across a 20 Kb region flanking the breakpoints of PDE9A partner sequences, and numbers of bp to the closest ZDRs and AluSx/AluSx1 sequences, for each observed or random breakpoint, were calculated using Microsoft word. Breakpoint sequences were examined for possible sites of mistargeted RAG1 recombination. The minimum sequence considered a potential target for V(D)J-type RAG activity consisted of CAC (+ strand) or GTG (2 strand). Potential targets for CpG-type RAG1 activity were CG (+ strand) or GC (2 strand). When breakpoints could only be defined to within a region of microhomology, the middle of the microhomologous sequence was taken as the breakpoint. In instances where a CG/GC or CAC/GTG sequence fell completely or partly within a region of microhomology, distances were
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Human Molecular Genetics, 2011, Vol. 20, No. 13 calculated to each of the potential breakpoints within the region and the mean of these distances was used. Random breakpoints were assigned to every 40 bp across the 1.7 Kb PDE9A BCR and distances for observed and random breakpoints to the nearest CAC, GTG, CG and GC sequences calculated using Microsoft word. The Wilcoxon Mann -Whitney test, in Stata version 11.1, was used to determine the statistical significance of differences between observed and randomly generated breakpoints. Free energy levels required for unwinding supercoiled double-stranded DNA (DG) were compared across intron one of PDE9A using the WEB-THERMODYN; http://www. gsa.buffalo.edu/dna/dk/WEBTHERMODYN//index.html (46) .
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